139. Breast Cancer Res Treat. 2018 Jun;169(3):407-412. doi: 10.1007/s10549-018-4692-3.Epub 2018 Feb 8.First international TNBC conference meeting report.Rida P(1)(2), Ogden A(1), Ellis IO(3), Varga Z(4), Wolff AC(5), Traina TA(6)(7), Hatzis C(8), Palmer JR(9), Ambrosone CB(10), Lehmann BD(11), Nanda R(12),Montgomery Rice V(13), Brawley OW(14), Torres MA(15)(16), Rakha E(3), AnejaR(17).Author information: (1)Department of Biology, Georgia State University, Atlanta, GA, USA.(2)Novazoi Theranostics, Rolling Hills Estates, CA, USA.(3)Department of Histopathology, Nottingham City Hospital NHS Trust, NottinghamUniversity, Nottingham, UK.(4)Department of Pathology and Molecular Pathology, University Hospital Zurich,Zurich, Switzerland.(5)The Johns Hopkins Kimmel Comprehensive Cancer Center, Baltimore, MD, USA.(6)Breast Medicine Service, Memorial Sloan Kettering Cancer Center, New York, NY,USA.(7)Weill Cornell Medicine, New York, NY, USA.(8)Department of Medicine, Breast Medical Oncology, Yale School of Medicine, YaleUniversity, New Haven, CT, USA.(9)Slone Epidemiology Center, Boston University, Boston, MA, USA.(10)Department of Cancer Prevention and Control, Roswell Park ComprehensiveCancer Center, Buffalo, NY, USA.(11)Department of Biochemistry, Vanderbilt University, Nashville, TN, USA.(12)Section of Hematology-Oncology, Department of Medicine, The University ofChicago, Chicago, IL, USA.(13)Morehouse School of Medicine, Atlanta, GA, USA.(14)American Cancer Society, Atlanta, GA, USA.(15)Department of Radiation Oncology, Emory University, Atlanta, GA, USA.(16)Glenn Family Breast Center, Winship Cancer Institute, Emory University,Atlanta, GA, USA.(17)Department of Biology, Georgia State University, Atlanta, GA, USA.raneja@gsu.edu.Recently, Georgia State University's Centennial Hall was the premier location forthe 2017 International Conference on Triple Negative Breast Cancer (TNBC):Illuminating Actionable Biology, which was held from Sept. 18 to 20, 2017, inAtlanta, USA. The conference featured a stellar line-up of domestic andinternational speakers and diverse participants including TNBC survivors,luminaries in breast cancer research, medical students and fellows, clinicians,translational researchers, epidemiologists, biostatisticians, bioinformaticians, and representatives from the industry. This report distills the burning questionsthat spiked the event and summarizes key themes, findings, unique opportunitiesand future directions that emerged from this confluence of thought leaders.DOI: 10.1007/s10549-018-4692-3 PMCID: PMC5955852 [Available on 2019-06-01]PMID: 29417299 